ARCA biopharma’s AB201 secures IND approval for Covid-19 trial,

ARCA plans to start the sequential Phase IIb/III ASPEN-COVID-19 study of the drug candidate in around 100 patients in the fourth quarter of this year., ARCA plans to start the sequential Phase IIb/III ASPEN-COVID-19 study of the drug candidate in around 100 patients in the fourth quarter of this year., Read More